Delivery Order SPE2DB20D1100-SPE2DB24FA5L3
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Lidocaine 5% Patches. The contract has a ceiling value of $1,287.86 and a completion date of May 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,709.61 to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of 4,564,340,251 units of Lidocaine 5% Patch 30s, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lidocaine 5% patches. The firm-fixed-price contract has a ceiling value of $6,305.30 and a period of performance through January 31, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, valued at $11,370.41, for the supply of 5% lidocaine patches. The contract has an ultimate completion date of September 30, 2024 and is not set-aside. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical commodities, including prescription drugs, vaccines, and medical supplies, to...
- The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lidocaine 5% patches. This $3,707.92 firm-fixed-price contract has a completion date of January 23, 2023 and was awarded on December 22, 2022. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $1,213.09 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Lidocaine 5% Patches. This Delivery Order is a part of a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen, with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for AmerisourceBergen to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,107,006 units of Lidocaine 5% Patch 30s. The $1,808.79 contract has a performance period through March 29, 2024 and does not contain a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,399.62 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, with a performance period through March 14, 2024. This delivery order is issued under a larger, single-award indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp,...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide $3,108.60 worth of Lidocaine 5% patches. The contract has a completion date of February 28, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization based in Conshohocken, Pennsylvania. This award is part of a larger indefinite...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $9,282.40 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract, with a performance period through August 7, 2024, is for the supply of Lidocaine 5% Patch 30s, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999 held by AmerisourceBergen with DLA Troop Support Medical for providing a...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA5L3Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, a firm fixed price delivery order contract valued at $7,528.53 to provide Lidocaine 5% patches. The contract has a performance period through March 5, 2024 and does not include a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, holds an indefinite delivery contract with a potential value of $999,999,999.00 from DLA to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This single award indefinite delivery contract serves as the primary vehicle for Amerisourcebergen to provide pharmaceuticals and medical materials to military treatment programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 3/4/24 |